UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000009318
Receipt No. R000010945
Scientific Title A Phase II trial of irinotecan / S-1 (IRIS) + alfa (Panitumumab/Bevacizumab) as 2nd line chemotherapy for metastatic colorectal cancer (mCRC) A multicenter phase II trial of TS1 + Irinotecan (IRIS) + Bevacizumab as second line treatment in patients with KRAS mutant type unresectable advanced colorectal cancer (mCRC).
Date of disclosure of the study information 2012/11/12
Last modified on 2015/05/12 11:07:43

No. Disposal Last modified on Item of update
1 Insert 2012/11/12 16:32:43
2 Update 2015/05/12 11:07:04 Email
Email
3 Update 2015/05/12 11:07:43 Recruitment status


Contact us.